Retargeting of T-cell-receptor gamma/delta+ lymphocytes against tumor cells by bispecific monoclonal antibodies. Induction of cytolytic activity and lymphokine production

This publication has 8 references indexed in Scilit:

• Monoclonal antibodies which react with the T cell receptor γ/δ recognize different subsets of CD3WT31^‐ T lymphocytes
  European Journal of Immunology, 1989
• Specificity and function of T cells bearing γδ receptors
  Immunology Today, 1988
• Two subsets of human T lymphocytes expressing gamma/delta antigen receptor are identifiable by monoclonal antibodies directed to two distinct molecular forms of the receptor.
  The Journal of Experimental Medicine, 1988
• A monoclonal antibody specific for a common determinant of the human T cell receptor gamma/delta directly activates CD3+WT31- lymphocytes to express their functional program(s).
  The Journal of Experimental Medicine, 1988
• Characterization of CD3+, CD4-, CD8- clones expressing the putative T cell receptor gamma gene product. Analysis of the activation pathways leading to interleukin 2 production and triggering of the lytic machinery.
  The Journal of Experimental Medicine, 1987
• Characterization of human ovarian carcinoma‐associated antigens defined by novel monoclonal antibodies with tumor‐restricted specificity
  International Journal of Cancer, 1987
• Two forms of the T-cell receptor γ protein found on peripheral blood cytotoxic T lymphocytes
  Nature, 1987
• Hybrid hybridoma producing a bispecific monoclonal antibody that can focus effector T-cell activity.
  Proceedings of the National Academy of Sciences, 1986